Express Pharma

The future CRO/CDMO will offer end-to-end solutions and operate as a large pharma or biotech company

Dr Mahesh Bhalgat, COO, Syngene talks about his company's outlook, investments and capacity expansion, as well as Syngene's plans to strengthen its position as an integrated full-value service provider, in an exclusive interview with Lakshmipriya Nair